Fortress Biotech, Inc. (FBIO)
NASDAQ: FBIO · Real-Time Price · USD
1.785
-0.015 (-0.83%)
Jan 28, 2025, 4:00 PM EST - Market closed
Fortress Biotech Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Fortress Biotech stock have an average target of 18, with a low estimate of 10 and a high estimate of 26. The average target predicts an increase of 908.40% from the current stock price of 1.79.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 18, 2024.
Analyst Ratings
The average analyst rating for FBIO stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $24 → $26 | Strong Buy | Maintains | $24 → $26 | +1,356.58% | Nov 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $24 | Strong Buy | Reiterates | $24 | +1,244.54% | Jul 19, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 20, 2024 |
| Roth MKM | Roth MKM | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +460.22% | May 16, 2024 |
| Roth MKM | Roth MKM | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +460.22% | Mar 15, 2024 |
Financial Forecast
Revenue This Year
60.03M
from 84.51M
Decreased by -28.97%
Revenue Next Year
137.25M
from 60.03M
Increased by 128.63%
EPS This Year
-3.28
from -8.47
EPS Next Year
-1.51
from -3.28
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 63.3M | 189.6M | 251.7M |
| Avg | 60.0M | 137.3M | 202.4M |
| Low | 55.7M | 90.5M | 154.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -25.1% | 215.8% | 83.4% |
| Avg | -29.0% | 128.6% | 47.4% |
| Low | -34.1% | 50.7% | 12.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -3.31 | -0.91 | 0.24 |
| Avg | -3.28 | -1.51 | -0.43 |
| Low | -3.21 | -2.16 | -1.05 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.